The risk of developing esophageal adenocarcinoma for patients with Barrett's esophagus is less than 1% per year.
Dr Marie-Louise Essink-Bot and colleagues from the Netherlands investigated how patients with Barrett's esophagus estimate and perceive their risk of developing esophageal adenocarcinoma.
The researchers sent out a questionnaire to 192 patients with Barrett's esophagus based on histologic and flow cytometric results.
The patients were undergoing surveillance endoscopy.
The researchers asked individual patients to estimate the numerical risk to develop esophageal adenocarcinoma.
|69% underestimated their own risk of esophageal cancer|
The patients were asked to estimate the risk for patients with Barrett's esophagus in general, and for themselves.
The research team measured how patients perceived their own risk on a scale from ‘very small' to ‘very large'.
At least 1 question was filled out by 169 patients.
The researchers reported that 60% of respondents underestimated the numerical risk of cancer for patients with Barrett's esophagus, in general.
The team found that 69% of patients underestimated their own risk of esophageal adenocarcinoma.
The research team observed that 63% of respondents perceived their own risk as very small or small.
Dr Essink-Bot's team concludes, “Most patients with Barrett's esophagus underestimated the numerical risk and perceived their risk of developing esophageal adenocarcinoma as very low.”
“Despite a low perceived risk, all patients in this group adhered to endoscopic surveillance.”